<DOC>
	<DOCNO>NCT01357668</DOCNO>
	<brief_summary>The purpose study examine long-term safety Abatacept treatment juvenile idiopathic arthritis ( JIA ) particular interest occurrence serious infection , autoimmune disorder , malignancy .</brief_summary>
	<brief_title>An Observational Registry Abatacept Patients With Juvenile Idiopathic Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Juvenile</mesh_term>
	<mesh_term>Abatacept</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Diagnosis JIA ( subtype ) Age &lt; 18 year time enrollment unless currently previously enrol abatacept clinical trial receive abatacept Receiving Abatacept time enrollment per treat physician 's decision receive abatacept clinical trial Parent legally acceptable representative willing participate study sign inform consent Pregnant nursing female time enrollment Prior malignancy patient malignancy free least 5 year . Any serious acute chronic medical condition JIA , include chronic infection , would compromise patient 's ability participate study Known poor compliance clinic visit ( base physician judgment )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>